These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An in vivo model for the study of ovarian cancer and the persistence of characteristic mutations in xenografts. Li Y, Gu YJ, Liu CN, Yue TF. Eur J Gynaecol Oncol; 2014; 35(4):387-92. PubMed ID: 25118479 [Abstract] [Full Text] [Related]
7. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Mayr D, Hirschmann A, Löhrs U, Diebold J. Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438 [Abstract] [Full Text] [Related]
10. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. McCluggage WG. Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157 [Abstract] [Full Text] [Related]
14. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas]. Zhang X, Wang Y, Gao N, Wang J. Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565 [Abstract] [Full Text] [Related]
17. Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma. Gemignani ML, Schlaerth AC, Bogomolniy F, Barakat RR, Lin O, Soslow R, Venkatraman E, Boyd J. Gynecol Oncol; 2003 Aug; 90(2):378-81. PubMed ID: 12893203 [Abstract] [Full Text] [Related]